A Study of Matr3 and Its Effects on the Neural Progenitor Cells of Xenopus Laevis Tadpoles
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
RT² Profiler PCR Array (96-Well Format and 384-Well [4 X 96] Format)
RT² Profiler PCR Array (96-Well Format and 384-Well [4 x 96] Format) Human Mitochondria Cat. no. 330231 PAHS-087ZA For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Applied Biosystems® models 5700, 7000, 7300, 7500, Format A 7700, 7900HT, ViiA™ 7 (96-well block); Bio-Rad® models iCycler®, iQ™5, MyiQ™, MyiQ2; Bio-Rad/MJ Research Chromo4™; Eppendorf® Mastercycler® ep realplex models 2, 2s, 4, 4s; Stratagene® models Mx3005P®, Mx3000P®; Takara TP-800 RT² Profiler PCR Array, Applied Biosystems models 7500 (Fast block), 7900HT (Fast Format C block), StepOnePlus™, ViiA 7 (Fast block) RT² Profiler PCR Array, Bio-Rad CFX96™; Bio-Rad/MJ Research models DNA Format D Engine Opticon®, DNA Engine Opticon 2; Stratagene Mx4000® RT² Profiler PCR Array, Applied Biosystems models 7900HT (384-well block), ViiA 7 Format E (384-well block); Bio-Rad CFX384™ RT² Profiler PCR Array, Roche® LightCycler® 480 (96-well block) Format F RT² Profiler PCR Array, Roche LightCycler 480 (384-well block) Format G RT² Profiler PCR Array, Fluidigm® BioMark™ Format H Sample & Assay Technologies Description The Human Mitochondria RT² Profiler PCR Array profiles the expression of 84 genes involved in the biogenesis and function of the cell's powerhouse organelle. The genes monitored by this array include regulators and mediators of mitochondrial molecular transport of not only the metabolites needed for the electron transport chain and oxidative phosphorylation, but also the ions required for maintaining the mitochondrial membrane polarization and potential important for ATP synthesis. Metabolism and energy production are not the only functions of mitochondria. -
Downloads/ (Accessed on 17 January 2020)
cells Review Novel Approaches for Identifying the Molecular Background of Schizophrenia Arkadiy K. Golov 1,2,*, Nikolay V. Kondratyev 1 , George P. Kostyuk 3 and Vera E. Golimbet 1 1 Mental Health Research Center, 34 Kashirskoye shosse, 115522 Moscow, Russian; [email protected] (N.V.K.); [email protected] (V.E.G.) 2 Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilova Street, 119334 Moscow, Russian 3 Alekseev Psychiatric Clinical Hospital No. 1, 2 Zagorodnoye shosse, 115191 Moscow, Russian; [email protected] * Correspondence: [email protected] Received: 5 November 2019; Accepted: 16 January 2020; Published: 18 January 2020 Abstract: Recent advances in psychiatric genetics have led to the discovery of dozens of genomic loci associated with schizophrenia. However, a gap exists between the detection of genetic associations and understanding the underlying molecular mechanisms. This review describes the basic approaches used in the so-called post-GWAS studies to generate biological interpretation of the existing population genetic data, including both molecular (creation and analysis of knockout animals, exploration of the transcriptional effects of common variants in human brain cells) and computational (fine-mapping of causal variability, gene set enrichment analysis, partitioned heritability analysis) methods. The results of the crucial studies, in which these approaches were used to uncover the molecular and neurobiological basis of the disease, are also reported. Keywords: schizophrenia; GWAS; causal genetic variants; enhancers; brain epigenomics; genome/epigenome editing 1. Introduction Schizophrenia is a severe mental illness that affects between 0.5% and 0.7% of the human population [1]. Both environmental and genetic factors are thought to be involved in its pathogenesis, with genetic factors playing a key role in disease risk, as the heritability of schizophrenia is estimated to be 70–85% [2,3]. -
Association of Imputed Prostate Cancer Transcriptome with Disease Risk Reveals Novel Mechanisms
Corrected: Author Correction ARTICLE https://doi.org/10.1038/s41467-019-10808-7 OPEN Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms Nima C. Emami1,2, Linda Kachuri2, Travis J. Meyers2, Rajdeep Das3,4, Joshua D. Hoffman2, Thomas J. Hoffmann 2,5, Donglei Hu 5,6,7, Jun Shan8, Felix Y. Feng3,4,7, Elad Ziv5,6,7, Stephen K. Van Den Eeden 3,8 & John S. Witte1,2,3,5,7 1234567890():,; Here we train cis-regulatory models of prostate tissue gene expression and impute expression transcriptome-wide for 233,955 European ancestry men (14,616 prostate cancer (PrCa) cases, 219,339 controls) from two large cohorts. Among 12,014 genes evaluated in the UK Biobank, we identify 38 associated with PrCa, many replicating in the Kaiser Permanente RPGEH. We report the association of elevated TMPRSS2 expression with increased PrCa risk (independent of a previously-reported risk variant) and with increased tumoral expression of the TMPRSS2:ERG fusion-oncogene in The Cancer Genome Atlas, suggesting a novel germline-somatic interaction mechanism. Three novel genes, HOXA4, KLK1, and TIMM23, additionally replicate in the RPGEH cohort. Furthermore, 4 genes, MSMB, NCOA4, PCAT1, and PPP1R14A, are associated with PrCa in a trans-ethnic meta-analysis (N = 9117). Many genes exhibit evidence for allele-specific transcriptional activation by PrCa master-regulators (including androgen receptor) in Position Weight Matrix, Chip-Seq, and Hi-C experimental data, suggesting common regulatory mechanisms for the associated genes. 1 Program in Biological and Medical Informatics, University of California San Francisco, San Francisco, CA 94158, USA. -
Human CLPB) Is a Potent Mitochondrial Protein Disaggregase That Is Inactivated By
bioRxiv preprint doi: https://doi.org/10.1101/2020.01.17.911016; this version posted January 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Skd3 (human CLPB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations Ryan R. Cupo1,2 and James Shorter1,2* 1Department of Biochemistry and Biophysics, 2Pharmacology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, U.S.A. *Correspondence: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.17.911016; this version posted January 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT Cells have evolved specialized protein disaggregases to reverse toxic protein aggregation and restore protein functionality. In nonmetazoan eukaryotes, the AAA+ disaggregase Hsp78 resolubilizes and reactivates proteins in mitochondria. Curiously, metazoa lack Hsp78. Hence, whether metazoan mitochondria reactivate aggregated proteins is unknown. Here, we establish that a mitochondrial AAA+ protein, Skd3 (human CLPB), couples ATP hydrolysis to protein disaggregation and reactivation. The Skd3 ankyrin-repeat domain combines with conserved AAA+ elements to enable stand-alone disaggregase activity. A mitochondrial inner-membrane protease, PARL, removes an autoinhibitory peptide from Skd3 to greatly enhance disaggregase activity. Indeed, PARL-activated Skd3 dissolves α-synuclein fibrils connected to Parkinson’s disease. Human cells lacking Skd3 exhibit reduced solubility of various mitochondrial proteins, including anti-apoptotic Hax1. -
Skd3 (Human CLPB) Is a Potent Mitochondrial Protein Disaggregase That Is Inactivated By
bioRxiv preprint first posted online Jan. 18, 2020; doi: http://dx.doi.org/10.1101/2020.01.17.911016. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Skd3 (human CLPB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations Ryan R. Cupo1,2 and James Shorter1,2* 1Department of Biochemistry and Biophysics, 2Pharmacology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, U.S.A. *Correspondence: [email protected] 1 bioRxiv preprint first posted online Jan. 18, 2020; doi: http://dx.doi.org/10.1101/2020.01.17.911016. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. ABSTRACT Cells have evolved specialized protein disaggregases to reverse toxic protein aggregation and restore protein functionality. In nonmetazoan eukaryotes, the AAA+ disaggregase Hsp78 resolubilizes and reactivates proteins in mitochondria. Curiously, metazoa lack Hsp78. Hence, whether metazoan mitochondria reactivate aggregated proteins is unknown. Here, we establish that a mitochondrial AAA+ protein, Skd3 (human CLPB), couples ATP hydrolysis to protein disaggregation and reactivation. The Skd3 ankyrin-repeat domain combines with conserved AAA+ elements to enable stand-alone disaggregase activity. A mitochondrial inner-membrane protease, PARL, removes an autoinhibitory peptide from Skd3 to greatly enhance disaggregase activity. Indeed, PARL-activated Skd3 dissolves α-synuclein fibrils connected to Parkinson’s disease. -
RNA-Recognition Motif in Matrin-3 Mediates Neurodegeneration
Ramesh et al. acta neuropathol commun (2020) 8:138 https://doi.org/10.1186/s40478-020-01021-5 RESEARCH Open Access RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM Nandini Ramesh1,2, Sukhleen Kour1, Eric N. Anderson1, Dhivyaa Rajasundaram3 and Udai Bhan Pandey1,2* Abstract Background: Amyotrophic lateral sclerosis (ALS) is an adult-onset, fatal neurodegenerative disease characterized by progressive loss of upper and lower motor neurons. While pathogenic mutations in the DNA/RNA-binding protein Matrin-3 (MATR3) are linked to ALS and distal myopathy, the molecular mechanisms underlying MATR3-mediated neuromuscular degeneration remain unclear. Methods: We generated Drosophila lines with transgenic insertion of human MATR3 wildtype, disease-associated variants F115C and S85C, and deletion variants in functional domains, ΔRRM1, ΔRRM2, ΔZNF1 and ΔZNF2. We utilized genetic, behavioral and biochemical tools for comprehensive characterization of our models in vivo and in vitro. Additionally, we employed in silico approaches to fnd transcriptomic targets of MATR3 and hnRNPM from publicly available eCLIP datasets. Results: We found that targeted expression of MATR3 in Drosophila muscles or motor neurons shorten lifespan and produces progressive motor defects, muscle degeneration and atrophy. Strikingly, deletion of its RNA-recognition motif (RRM2) mitigates MATR3 toxicity. We identifed rump, the Drosophila homolog of human RNA-binding protein hnRNPM, as a modifer of mutant MATR3 toxicity in vivo. Interestingly, hnRNPM physically and functionally interacts with MATR3 in an RNA-dependent manner in mammalian cells. Furthermore, common RNA targets of MATR3 and hnRNPM converge in biological processes important for neuronal health and survival. Conclusions: We propose a model of MATR3-mediated neuromuscular degeneration governed by its RNA-binding domains and modulated by interaction with splicing factor hnRNPM. -
Glucocorticoid-Induced Alterations in Mitochondrial Membrane Properties and Respiration in Childhood Acute Lymphoblastic Leukemia☆
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1807 (2011) 719–725 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbabio Glucocorticoid-induced alterations in mitochondrial membrane properties and respiration in childhood acute lymphoblastic leukemia☆ Karin Eberhart a,c, Johannes Rainer b,c, Daniel Bindreither b, Ireen Ritter a, Erich Gnaiger d, Reinhard Kofler b,c, Peter J. Oefner a, Kathrin Renner a,⁎ a Institute of Functional Genomics, University of Regensburg, Josef-Engert-Str. 9, 93053 Regensburg, Germany b Division of Molecular Pathophysiology, Biocenter, Medical University of Innsbruck, Innrain 52, 6020 Innsbruck, Austria c Tyrolean Cancer Research Institute, Innrain 66, 6020 Innsbruck, Austria d D. Swarovski Research Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Innrain 66, 6020 Innsbruck, Austria article info abstract Article history: Mitochondria are signal-integrating organelles involved in cell death induction. Mitochondrial alterations and Received 26 July 2010 reduction in energy metabolism have been previously reported in the context of glucocorticoid (GC)- Received in revised form 13 December 2010 triggered apoptosis, although the mechanism is not yet clarified. We analyzed mitochondrial function in a GC- Accepted 18 December 2010 sensitive precursor B-cell acute lymphoblastic leukemia (ALL) model as well as in GC-sensitive and GC- Available online 13 January 2011 resistant T-ALL model systems. Respiratory activity was preserved in intact GC-sensitive cells up to 24 h under treatment with 100 nM dexamethasone before depression of mitochondrial respiration occurred. Severe Keywords: Glucocorticoid repression of mitochondrial respiratory function was observed after permeabilization of the cell membrane Acute lymphoblastic leukemia and provision of exogenous substrates. -
(12) Patent Application Publication (10) Pub. No.: US 2009/00992.59 A1 Jouni Et Al
US 200900992.59A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/00992.59 A1 Jouni et al. (43) Pub. Date: Apr. 16, 2009 (54) METHOD FOR REGULATING GENE Related U.S. Application Data EXPRESSION (60) Provisional application No. 60/777,724, filed on Feb. (76) Inventors: Zeina Jouni, Evansville, IN (US); 28, 2006. Joshua Anthony, Evansville, IN (US); Steven C. Rumsey, Curitiba Publication Classification (BR): Deshanie Rai, Evansville, IN (US); Kumar Sesha Kothapalli, (51) Int. Cl. Ithaca, NY (US); James T. Brenna, A6II 3L/20 (2006.01) Ithaca, NY (US) A6IP3/00 (2006.01) A6IP 25/00 (2006.01) Correspondence Address: A6IP37/00 (2006.01) Richard D. Schmidt Bristol-Myers Squibb Company (52) U.S. Cl. ........................................................ 514/560 2400 West Lloyd Expressay Evansville, IN 47721-0001 (US) (57) ABSTRACT (21) Appl. No.: 11/712,102 The present invention is directed to a novel method for modu lating the expression of one or more genes in a subject by (22) Filed: Feb. 28, 2007 administering an amount of DHA and ARA to the subject. ::::::: Patent Application Publication Apr. 16, 2009 US 2009/00992.59 A1 s :::::::::: US 2009/00992.59 A1 Apr. 16, 2009 METHOD FOR REGULATING GENE expression of certain genes in Subjects and thereby prevent EXPRESSION the onset of or treat various diseases and disorders. SUMMARY OF THE INVENTION 0001. This application claims the priority benefit of U.S. 0011 Briefly, the present invention is directed to a novel Provisional Application 60/777,724 filed Feb. 28, 2006 which method for modulating the expression of one or more genes in is incorporated by reference herein in its entirety. -
Function of Htim8a in Complex IV Assembly in Neuronal Cells
RESEARCH ARTICLE Function of hTim8a in complex IV assembly in neuronal cells provides insight into pathomechanism underlying Mohr-Tranebjærg syndrome Yilin Kang1,2, Alexander J Anderson1,2, Thomas Daniel Jackson1,2, Catherine S Palmer1,2, David P De Souza3, Kenji M Fujihara4,5, Tegan Stait6,7, Ann E Frazier6,7, Nicholas J Clemons4,5, Deidreia Tull3, David R Thorburn6,7,8, Malcolm J McConville3, Michael T Ryan9, David A Stroud1,2, Diana Stojanovski1,2* 1Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, Australia; 2The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Australia; 3Metabolomics Australia, The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Australia; 4Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia; 5Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia; 6Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Australia; 7Department of Paediatrics, University of Melbourne, Melbourne, Australia; 8Victorian Clinical Genetic Services, Royal Children’s Hospital, Melbourne, Australia; 9Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Australia Abstract Human Tim8a and Tim8b are members of an intermembrane space chaperone network, known as the small TIM family. Mutations in TIMM8A cause a neurodegenerative disease, *For correspondence: Mohr-Tranebjærg syndrome (MTS), which is characterised by sensorineural hearing loss, dystonia [email protected] and blindness. Nothing is known about the function of hTim8a in neuronal cells or how mutation of Competing interests: The this protein leads to a neurodegenerative disease. We show that hTim8a is required for the authors declare that no assembly of Complex IV in neurons, which is mediated through a transient interaction with competing interests exist. -
Tau Modulates Mrna Transcription, Alternative Polyadenylation Profiles of Hnrnps, Chromatin Remodeling and Spliceosome Complexes
bioRxiv preprint doi: https://doi.org/10.1101/2021.07.16.452616; this version posted July 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Tau modulates mRNA transcription, alternative 2 polyadenylation profiles of hnRNPs, chromatin remodeling 3 and spliceosome complexes 4 5 Montalbano Mauro1,2, Elizabeth Jaworski3, Stephanie Garcia1,2, Anna Ellsworth1,2, 6 Salome McAllen1,2, Andrew Routh3,4 and Rakez Kayed1,2†. 7 8 1 Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, 9 77555, USA 10 2 Departments of Neurology, Neuroscience and Cell Biology, University of Texas Medical Branch, 11 Galveston, Texas, 77555, USA 12 3 Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas 13 77555, USA 14 4Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, 15 Galveston, TX, USA 16 † To whom correspondence should be addressed 17 18 Corresponding Author 19 Rakez Kayed, PhD 20 University of Texas Medical Branch 21 Medical Research Building Room 10.138C 22 301 University Blvd 23 Galveston, TX 77555-1045 24 Phone: 409.772.0138 25 Fax: 409.747.0015 26 e-mail: [email protected] 27 28 Running Title: Tau modulates transcription and alternative polyadenilation processes 29 30 Keywords: Tau, Transcriptomic, Alternative Polyadenilation, -
Host Protein Interactions
scientificscientificreport report Structure homology and interaction redundancy for discovering virus–host protein interactions Benoıˆt de Chassey 1,Laure`ne Meyniel-Schicklin 2,3, Anne Aublin-Gex 2,3, Vincent Navratil 2,3,w, Thibaut Chantier 2,3, Patrice Andre´1,2,3 &VincentLotteau2,3+ 1Hospices Civils de Lyon, Hoˆpital de la Croix-Rousse, Laboratoire de virologie, Lyon , 2Inserm, U1111, Lyon , and 3Universite´ de Lyon, Lyon, France Virus–host interactomes are instrumental to understand global purification coupled to mass spectrometry, led to the publication perturbations of cellular functions induced by infection and of the first virus–host interactomes [3–4]. Although incorporation discover new therapies. The construction of such interactomes is, of data from different methods or variation of the same method [5] however, technically challenging and time consuming. Here we has improved the quality of the data sets, diversification of describe an original method for the prediction of high-confidence methods is still clearly needed to generate high-quality interactions between viral and human proteins through comprehensive virus–host interactomes. In addition, regarding a combination of structure and high-quality interactome data. the size of host genome and the huge diversity of viruses, millions Validation was performed for the NS1 protein of the influenza of binary interactions remain to be tested. Therefore, accurate and virus, which led to the identification of new host factors that rapid methods for the identification of cellular interactors control viral replication. controlling viral replication is a major issue and a crucial step Keywords: interactome; prediction; protein interaction; towards the selection of original therapeutic targets and drug structure; virus development. -
Diverse Functions of Tim50, a Component of the Mitochondrial Inner Membrane Protein Translocase
International Journal of Molecular Sciences Review Diverse Functions of Tim50, a Component of the Mitochondrial Inner Membrane Protein Translocase Minu Chaudhuri *, Anuj Tripathi and Fidel Soto Gonzalez Department of Microbiology, Immunology, and Physiology, Meharry Medical College, Nashville, TN 37208, USA; [email protected] (A.T.); [email protected] (F.S.G.) * Correspondence: [email protected]; Tel.: +1-615-327-5726 Abstract: Mitochondria are essential in eukaryotes. Besides producing 80% of total cellular ATP, mito- chondria are involved in various cellular functions such as apoptosis, inflammation, innate immunity, stress tolerance, and Ca2+ homeostasis. Mitochondria are also the site for many critical metabolic pathways and are integrated into the signaling network to maintain cellular homeostasis under stress. Mitochondria require hundreds of proteins to perform all these functions. Since the mitochondrial genome only encodes a handful of proteins, most mitochondrial proteins are imported from the cytosol via receptor/translocase complexes on the mitochondrial outer and inner membranes known as TOMs and TIMs. Many of the subunits of these protein complexes are essential for cell survival in model yeast and other unicellular eukaryotes. Defects in the mitochondrial import machineries are also associated with various metabolic, developmental, and neurodegenerative disorders in multicellular organisms. In addition to their canonical functions, these protein translocases also help maintain mitochondrial structure and dynamics, lipid metabolism, and stress response. This review focuses on the role of Tim50, the receptor component of one of the TIM complexes, in different cellular Citation: Chaudhuri, M.; Tripathi, functions, with an emphasis on the Tim50 homologue in parasitic protozoan Trypanosoma brucei. A.; Gonzalez, F.S.